Exposure-response characterisation of tofacitinib efficacy in moderate to severe ulcerative colitis: results from a dose-ranging phase 2 trial
Mukherjee, Arnab, Hazra, Anasuya, Smith, Mike K., Martin, Steven W., Mould, Diane R., Su, Chinyu, Niezychowski, WojciechLanguage:
english
Journal:
British Journal of Clinical Pharmacology
DOI:
10.1111/bcp.13523
Date:
January, 2018
File:
PDF, 1.24 MB
english, 2018